We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...
It’s a mysterious constellation of symptoms — brain fog, fatigue, heart palpitation, and others — that bind together those living with long Covid. It’s estimated 65 million or more people around the ...
Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-to-moderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients who are at standard risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results